Aclarubicin Hcl (Aclarubicin Hcl)
Overview of Aclarubicin Hcl
Aclarubicin Hcl is antibiotic with antineoplastic or anticancerous properties, belonging to the anthracycline group. Aclarubicin Hcl is effective in the treatment of different cancers (leukemias) to slow or stop the growth of cancerous cells or abnormal cells. Aclarubicin Hcl is used in combination with different anticancerous drugs to obtain best therapeutic results and to reduce toxicity or side effects. Aclarubicin Hcl is administered intravenously.
Indication of Aclarubicin Hcl
Aclarubicin Hcl is primarily indicated in conditions like Acute non-lymphoblastic leukemia, Breast cancer, Gastric cancer, Lymphoma, Ovarian coma, Small cell lung cancer, Thyroid cancer.
Contraindication of Aclarubicin Hcl
Aclarubicin (HCl) is contraindicated in conditions like Neutropenia,Thrombocytopenia,Cardiac failure.
Side Effects of Aclarubicin Hcl
The severe or irreversible adverse effects of Aclarubicin (HCl), which give rise to further complications include Reversible ECG changes, Sinus tachycardia, Anemia, Hepatic insufficiency.,Aclarubicin (HCl) produces potentially life-threatening effects which include Congestive heart failure. which are responsible for the discontinuation of Aclarubicin (HCl) therapy.,The symptomatic adverse reactions produced by Aclarubicin (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Vomiting, Alopecia, Anorexia.
Precautions of Aclarubicin Hcl
Aclarubicin is not recommended for use during pregnancy or lactation. Immunosuppressent drug should not be given, where possible, to patients with acute infection, dosage reduction or withdrawal should be considered if infection develops, until the infection has been controlled. Blood counts and measurement of hemoglobin concentration should be carried out routinely; it helps to predict the onset of bone marrow depression. It must be handled with great care and avoid contact with skin and eyes and should not be inhaled.